Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Meropenem"" wg kryterium: Temat


Tytuł :
Antimicrobial susceptibility of plastic-associated bacteria isolated from the ocean to novel antibiotics (delafloxacin, meropenem/vaborbactam, ceftolozane/tazobactam, ceftobiprole) - Can environmental bacteria be predictors of persistence of antibiotic activity in clinical pathogens?
Autorzy :
Moore RE; School of Biological Sciences, Queen's University, 1-33 Chlorine Gardens, Belfast, BT9 5AJ, Northern Ireland, UK.
Millar BC; Northern Ireland Public Health Laboratory, Department of Bacteriology, Belfast City Hospital, Lisburn Road, Belfast, Northern Ireland, BT9 7AD, UK; School of Biomedical Sciences, Ulster University, Cromore Road, Coleraine, BT52 1SA, Northern Ireland, UK; Wellcome-Wolfson Institute For Experimental Medicine, Queen's University, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland, UK.
Moore JE; Northern Ireland Public Health Laboratory, Department of Bacteriology, Belfast City Hospital, Lisburn Road, Belfast, Northern Ireland, BT9 7AD, UK; School of Biomedical Sciences, Ulster University, Cromore Road, Coleraine, BT52 1SA, Northern Ireland, UK; Wellcome-Wolfson Institute For Experimental Medicine, Queen's University, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland, UK. Electronic address: .
Pokaż więcej
Źródło :
International journal of hygiene and environmental health [Int J Hyg Environ Health] 2020 May; Vol. 226, pp. 113498. Date of Electronic Publication: 2020 Feb 28.
Typ publikacji :
Letter; Comment
Journal Info :
Publisher: Urban & Fischer Country of Publication: Germany NLM ID: 100898843 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-131X (Electronic) Linking ISSN: 14384639 NLM ISO Abbreviation: Int J Hyg Environ Health Subsets: MEDLINE
MeSH Terms :
Anti-Bacterial Agents*
Meropenem*
Antarctic Regions ; Bacteria/drug effects ; Boronic Acids ; Cephalosporins ; Drug Resistance, Microbial ; Fluoroquinolones ; Islands ; Oceans and Seas ; Plastics ; Polystyrenes ; Tazobactam
Opinia redakcyjna
Tytuł :
Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial.
Autorzy :
Lutsar I; Institute of Translational Medicine, University of Tartu, Tartu, Estonia.
Chazallon C; INSERM SC10-US19, Villejuif, France.
Trafojer U; Women's and Children's Health Department, Neonatal Intensive Care Unit, Azienda Ospedaliera-University of Padua, Padua, Italy.
de Cabre VM; INSERM SC10-US19, Villejuif, France.
Auriti C; Department of Neonatology, Neonatal Intensive Care Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Bertaina C; University Department of Paediatrics, Immunological and Infectious Disease Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Calo Carducci FI; University Department of Paediatrics, Immunological and Infectious Disease Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Canpolat FE; Sağlık Bilimleri Üniversitesi, Zekai Tahir Burak Kadın Sağlığı Eğitim ve Araştırma Hastanesi, Neonatoloji Kliniği, Ankara, Turkey.
Esposito S; Pediatric Highly Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy.
Fournier I; INSERM SC10-US19, Villejuif, France.
Hallik M; Department of Intensive Care, Tallinn Children's Hospital, Tallinn, Estonia.
Heath PT; Paediatric Infectious Disease Research Group, Institute for Infection and Immunity, St George's University of London, London, United Kingdom.
Ilmoja ML; Institute of Translational Medicine, University of Tartu, Tartu, Estonia.; Department of Intensive Care, Tallinn Children's Hospital, Tallinn, Estonia.
Iosifidis E; 3rd Department of Pediatrics, Faculty of Medicine, Infectious Diseases Unit, Aristotle University School of Health Sciences, Hippokration Hospital, Thessaloniki, Greece.
Kuznetsova J; Tartu University Hospital, Clinic of Anaesthesiology and Intensive Care, Tartu, Estonia.
Meyer L; INSERM SC10-US19, Villejuif, France.
Metsvaht T; Institute of Translational Medicine, University of Tartu, Tartu, Estonia.; Tartu University Hospital, Clinic of Anaesthesiology and Intensive Care, Tartu, Estonia.
Mitsiakos G; 2nd Department of Neonatology, Faculty of Medicine, Aristotle University School of Health Sciences, Papageorgiou Hospital, Thessaloniki, Greece.
Pana ZD; 3rd Department of Pediatrics, Faculty of Medicine, Infectious Diseases Unit, Aristotle University School of Health Sciences, Hippokration Hospital, Thessaloniki, Greece.
Mosca F; Neonatal Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy.
Pugni L; Neonatal Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy.
Roilides E; 3rd Department of Pediatrics, Faculty of Medicine, Infectious Diseases Unit, Aristotle University School of Health Sciences, Hippokration Hospital, Thessaloniki, Greece.
Rossi P; University Department of Paediatrics, Immunological and Infectious Disease Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Sarafidis K; 1st Department of Neonatology, Faculty of Medicine, Aristotle University School of Health Sciences, Hippokration Hospital, Thessaloniki, Greece.
Sanchez L; Hospital Universitario Infantil LA PAZ- H. Carlos III, Madrid, Spain.
Sharland M; Paediatric Infectious Disease Research Group, Institute for Infection and Immunity, St George's University of London, London, United Kingdom.
Usonis V; Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Warris A; MRC Centre for Medical Mycology, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.
Aboulker JP; INSERM SC10-US19, Villejuif, France.
Giaquinto C; Department of Women's and Children's Health, University of Padova, Padova, Italy.
Pokaż więcej
Corporate Authors :
NeoMero Consortium
Źródło :
PloS one [PLoS One] 2020 Mar 04; Vol. 15 (3), pp. e0229380. Date of Electronic Publication: 2020 Mar 04 (Print Publication: 2020).
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS ONE Subsets: MEDLINE
MeSH Terms :
Standard of Care*
Meropenem/*therapeutic use
Neonatal Sepsis/*drug therapy
Female ; Humans ; Infant ; Male ; Meropenem/adverse effects ; Safety ; Treatment Outcome
Czasopismo naukowe
Tytuł :
In Vitro Efficacy of Meropenem-Cefmetazole Combination Therapy against New Delhi Metallo-β-lactamase-producing Enterobacteriaceae.
Autorzy :
Hagiya H; Department of Infection Control and Prevention, Osaka University Graduate School of Medicine, Osaka, Japan; Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. Electronic address: .
Sugawara Y; Research Institute for Microbial Diseases, Osaka University, Osaka, Japan. Electronic address: .
Tsutsumi Y; Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan; Meiji Seika Pharma Co., Ltd, Pharmaceutical Research Center, Yokohama, Japan. Electronic address: .
Akeda Y; Department of Infection Control and Prevention, Osaka University Graduate School of Medicine, Osaka, Japan; Research Institute for Microbial Diseases, Osaka University, Osaka, Japan. Electronic address: .
Yamamoto N; Department of Infection Control and Prevention, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: .
Sakamoto N; Research Institute for Microbial Diseases, Osaka University, Osaka, Japan. Electronic address: .
Shanmugakani RK; Department of Infection Control and Prevention, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: .
Abe R; Department of Infection Control and Prevention, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: .
Takeuchi D; Research Institute for Microbial Diseases, Osaka University, Osaka, Japan. Electronic address: .
Nishi I; Laboratory for Clinical Investigation, Osaka University Hospital, Osaka, Japan. Electronic address: .
Ishii Y; Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan. Electronic address: .
Hamada S; Research Institute for Microbial Diseases, Osaka University, Osaka, Japan. Electronic address: .
Tomono K; Department of Infection Control and Prevention, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: .
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2020 Mar; Vol. 55 (3), pp. 105905. Date of Electronic Publication: 2020 Jan 25.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7913 (Electronic) Linking ISSN: 09248579 NLM ISO Abbreviation: Int. J. Antimicrob. Agents Subsets: MEDLINE
MeSH Terms :
Anti-Bacterial Agents/*pharmacology
Cefmetazole/*pharmacology
Enterobacteriaceae/*drug effects
Enterobacteriaceae Infections/*drug therapy
Meropenem/*pharmacology
Anti-Bacterial Agents/therapeutic use ; Cefmetazole/therapeutic use ; Drug Therapy, Combination ; Enterobacteriaceae/metabolism ; Enterobacteriaceae Infections/microbiology ; Ertapenem/pharmacology ; Humans ; Meropenem/therapeutic use ; beta-Lactamases/biosynthesis
Czasopismo naukowe
Tytuł :
Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial.
Autorzy :
Benítez-Cano A; Department of Anaesthesiology and Surgical Intensive Care, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain. .; Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain. .
Luque S; Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain. .; Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain. .; Department of Molecular and Clinical Pharmacology, Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool and Royal Liverpool Broadgreen University Hospital Trust, Liverpool, UK. .
Sorlí L; Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.; Infectious Diseases Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.; CEXS-Universitat Pompeu Fabra, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.
Carazo J; Department of Anaesthesiology and Surgical Intensive Care, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.
Ramos I; Department of Anaesthesiology and Surgical Intensive Care, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.
Campillo N; Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.; Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.
Curull V; Universitat de Barcelona, Barcelona, Spain.; Respiratory Medicine Department, Hospital del Mar-IMIM (Hospital del Mar Research Institute) and CIBER de Enfermedades Respiratorias (CIBERES), ISCIII, Barcelona, Spain.
Sánchez-Font A; Universitat de Barcelona, Barcelona, Spain.; Respiratory Medicine Department, Hospital del Mar-IMIM (Hospital del Mar Research Institute) and CIBER de Enfermedades Respiratorias (CIBERES), ISCIII, Barcelona, Spain.
Vilaplana C; Laboratory Department, Laboratori de Referència de Catalunya, Barcelona, Spain.
Horcajada JP; Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.; Infectious Diseases Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.; CEXS-Universitat Pompeu Fabra, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.
Adalia R; Department of Anaesthesiology and Surgical Intensive Care, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.
Bermejo S; Department of Anaesthesiology and Surgical Intensive Care, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.
Samsó E; Department of Anaesthesiology and Surgical Intensive Care, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain.
Hope W; Department of Molecular and Clinical Pharmacology, Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool and Royal Liverpool Broadgreen University Hospital Trust, Liverpool, UK.
Grau S; Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.; Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.
Pokaż więcej
Źródło :
Critical care (London, England) [Crit Care] 2020 Feb 17; Vol. 24 (1), pp. 55. Date of Electronic Publication: 2020 Feb 17.
Typ publikacji :
Journal Article; Randomized Controlled Trial
Journal Info :
Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 9801902 Publication Model: Electronic Cited Medium: Internet ISSN: 1466-609X (Electronic) Linking ISSN: 13648535 NLM ISO Abbreviation: Crit Care Subsets: MEDLINE
MeSH Terms :
Anti-Bacterial Agents*/administration & dosage
Anti-Bacterial Agents*/pharmacokinetics
Cross Infection*/drug therapy
Healthcare-Associated Pneumonia*/drug therapy
Meropenem*/administration & dosage
Meropenem*/pharmacokinetics
Aged ; Female ; Humans ; Infusions, Intravenous ; Male ; Middle Aged ; Prospective Studies
Czasopismo naukowe
Tytuł :
Clinical cure rate and cost-effectiveness of carbapenem-sparing beta-lactams vs. meropenem for Gram-negative infections: A systematic review, meta-analysis, and cost-effectiveness analysis.
Autorzy :
Nguyen CP; Department of Medical Microbiology, Radboud University Medical Centre, 6525 GA Nijmegen, the Netherlands; Department of Pharmaceutical Administration and Economics, Hanoi University of Pharmacy, 13 Le Thanh Tong, Hanoi, Vietnam. Electronic address: .
Dan Do TN; Department of Medical Microbiology, Radboud University Medical Centre, 6525 GA Nijmegen, the Netherlands.
Bruggemann R; Department of Pharmacy, Radboud University Medical Centre, 6525 GA Nijmegen, the Netherlands.
Ten Oever J; Department of Internal Medicine, Radboud University Medical Centre, 6525 GA Nijmegen, the Netherlands.
Kolwijck E; Department of Medical Microbiology, Radboud University Medical Centre, 6525 GA Nijmegen, the Netherlands.
Adang EMM; Department of Health Evidence, Radboud University Medical Centre, 6525 GA Nijmegen, the Netherlands.
Wertheim HFL; Department of Medical Microbiology, Radboud University Medical Centre, 6525 GA Nijmegen, the Netherlands. Electronic address: .
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2019 Dec; Vol. 54 (6), pp. 790-797. Date of Electronic Publication: 2019 Jul 05.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
Journal Info :
Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7913 (Electronic) Linking ISSN: 09248579 NLM ISO Abbreviation: Int. J. Antimicrob. Agents Subsets: MEDLINE
MeSH Terms :
Cost-Benefit Analysis*
Anti-Bacterial Agents/*economics
Anti-Bacterial Agents/*therapeutic use
Gram-Negative Bacterial Infections/*drug therapy
Meropenem/*therapeutic use
beta-Lactams/*therapeutic use
Anti-Bacterial Agents/classification ; Humans ; Meropenem/classification ; Meropenem/economics ; beta-Lactams/classification ; beta-Lactams/economics
Czasopismo naukowe
Tytuł :
Pharmacokinetic/pharmacodynamic analysis of meropenem, by Monte Carlo simulation, in both plasma and cerebrospinal fluid in patients with cerebral hemorrhage after external ventricular drainage
.
Autorzy :
Kong L
Xu H
Wu C
Kong X
Yu M
Shi Q
Wu X
Pokaż więcej
Źródło :
International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2020 Jan; Vol. 58 (1), pp. 50-56.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Dustri-Verlag Dr. K. Feistle Country of Publication: Germany NLM ID: 9423309 Publication Model: Print Cited Medium: Print ISSN: 0946-1965 (Print) Linking ISSN: 09461965 NLM ISO Abbreviation: Int J Clin Pharmacol Ther Subsets: MEDLINE
MeSH Terms :
Cerebral Hemorrhage*
Drainage*
Anti-Bacterial Agents/*pharmacokinetics
Meropenem/*pharmacokinetics
Anti-Bacterial Agents/blood ; Anti-Bacterial Agents/cerebrospinal fluid ; Humans ; Meropenem/blood ; Meropenem/cerebrospinal fluid ; Microbial Sensitivity Tests ; Monte Carlo Method
Czasopismo naukowe
Tytuł :
Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI).
Autorzy :
Kongnakorn T; Evidera, The Ark, 201 Talgarth Road, Hammersmith, London W6 8BJ UK.
Eckmann C; 2Klinikum Peine, Academic Hospital of Medical University Hannover, Hannover, Germany.
Bassetti M; 3Infectious Diseases Clinic, Department of Health Sciences, University of Genoa, Genoa and Hospital Policlinico San Martino IRCCS, Genoa, Italy.
Tichy E; Evidera, Bég u. 3-5 / 520, Budapest, 1022 Hungary.
Di Virgilio R; 5Pfizer, Via Valbondione, 113, 00188 Rome, Italy.
Baillon-Plot N; 6Pfizer, 23-25 Avenue du Dr Lannelongue, 75014 Paris, France.
Charbonneau C; 6Pfizer, 23-25 Avenue du Dr Lannelongue, 75014 Paris, France.
Pokaż więcej
Źródło :
Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2019 Dec 21; Vol. 8, pp. 204. Date of Electronic Publication: 2019 Dec 21 (Print Publication: 2019).
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: BioMed Central Country of Publication: England NLM ID: 101585411 Publication Model: eCollection Cited Medium: Internet ISSN: 2047-2994 (Electronic) Linking ISSN: 20472994 NLM ISO Abbreviation: Antimicrob Resist Infect Control Subsets: MEDLINE
MeSH Terms :
Cost-Benefit Analysis*
Anti-Bacterial Agents/*therapeutic use
Azabicyclo Compounds/*therapeutic use
Ceftazidime/*therapeutic use
Cephalosporins/*therapeutic use
Intraabdominal Infections/*drug therapy
Meropenem/*therapeutic use
Tazobactam/*therapeutic use
Adult ; Anti-Bacterial Agents/economics ; Azabicyclo Compounds/economics ; Bacterial Infections/complications ; Bacterial Infections/drug therapy ; Bacterial Infections/economics ; Ceftazidime/economics ; Cephalosporins/economics ; Drug Combinations ; Hospitalization/economics ; Humans ; Intraabdominal Infections/economics ; Intraabdominal Infections/microbiology ; Italy ; Meropenem/economics ; Models, Economic ; Tazobactam/economics
Czasopismo naukowe
Tytuł :
Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem.
Autorzy :
Park SY; Department of Internal Medicine, Division of Infectious Disease, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea.
Si HJ; Department of Internal Medicine, Division of Infectious Disease, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea.
Eom JS; Department of Internal Medicine, Division of Infectious Disease, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea.
Lee JS; Department of Internal Medicine, Division of Infectious Disease, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea.
Pokaż więcej
Źródło :
The Journal of international medical research [J Int Med Res] 2019 Dec; Vol. 47 (12), pp. 5977-5985. Date of Electronic Publication: 2019 Oct 15.
Typ publikacji :
Comparative Study; Journal Article
Journal Info :
Publisher: Sage Publications Country of Publication: England NLM ID: 0346411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-2300 (Electronic) Linking ISSN: 03000605 NLM ISO Abbreviation: J. Int. Med. Res. Subsets: MEDLINE
MeSH Terms :
Drug Resistance, Microbial*/drug effects
Acinetobacter baumannii/*physiology
Bacteremia/*drug therapy
Bacteremia/*mortality
Colistin/*therapeutic use
Meropenem/*therapeutic use
Acinetobacter baumannii/drug effects ; Aged ; Bacteremia/microbiology ; Colistin/pharmacology ; Drug Therapy, Combination ; Female ; Humans ; Male ; Meropenem/pharmacology ; Microbial Sensitivity Tests ; Middle Aged ; Multivariate Analysis ; Risk Factors ; Survival Analysis
Czasopismo naukowe
Tytuł :
Adjustment of Modified Carbapenem Inactivation Method Conditions for Rapid Detection of Carbapenemase-Producing Acinetobacter baumannii .
Autorzy :
Vu TN; Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea.; Brain Korea 21 PLUS Project for Medical Science, Yonsei University, Seoul, Korea.
Byun JH; Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea.; Department of Laboratory Medicine, Gyeongsang National University College of Medicine, Gyeongsang National University Hospital, Jinju, Korea. ; .
D'Souza R; Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea.; J. Craig Venter Institute, Rockville, Maryland, USA.
Pinto NA; Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea.; Brain Korea 21 PLUS Project for Medical Science, Yonsei University, Seoul, Korea.
Nguyen LP; Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea.; Brain Korea 21 PLUS Project for Medical Science, Yonsei University, Seoul, Korea.
Yong D; Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea.
Chong Y; Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło :
Annals of laboratory medicine [Ann Lab Med] 2020 Jan; Vol. 40 (1), pp. 21-26.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Korean Society for Laboratory Medicine Country of Publication: Korea (South) NLM ID: 101571172 Publication Model: Print Cited Medium: Internet ISSN: 2234-3814 (Electronic) Linking ISSN: 22343806 NLM ISO Abbreviation: Ann Lab Med Subsets: MEDLINE
MeSH Terms :
Acinetobacter baumannii/*metabolism
Anti-Bacterial Agents/*metabolism
Bacterial Proteins/*metabolism
Disk Diffusion Antimicrobial Tests/*methods
Meropenem/*metabolism
beta-Lactamases/*metabolism
Acinetobacter baumannii/drug effects ; Acinetobacter baumannii/isolation & purification ; Anti-Bacterial Agents/pharmacology ; Bacterial Proteins/genetics ; Drug Resistance, Bacterial/drug effects ; Meropenem/pharmacology ; beta-Lactamases/genetics
Czasopismo naukowe
Tytuł :
Repurposing Peptidomimetic as Potential Inhibitor of New Delhi Metallo-β-lactamases in Gram-Negative Bacteria.
Autorzy :
Liu Y; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses , Yangzhou , Jiangsu 225009 , China.
Yang K
Jia Y
Wang Z; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses , Yangzhou , Jiangsu 225009 , China.
Pokaż więcej
Źródło :
ACS infectious diseases [ACS Infect Dis] 2019 Dec 13; Vol. 5 (12), pp. 2061-2066. Date of Electronic Publication: 2019 Oct 24.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: ACS Publications Country of Publication: United States NLM ID: 101654580 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2373-8227 (Electronic) Linking ISSN: 23738227 NLM ISO Abbreviation: ACS Infect Dis Subsets: MEDLINE
MeSH Terms :
Gram-Negative Bacterial Infections/*drug therapy
Meropenem/*administration & dosage
Peptidomimetics/*administration & dosage
beta-Lactamase Inhibitors/*administration & dosage
beta-Lactamases/*metabolism
Animals ; Disease Models, Animal ; Drug Repositioning ; Drug Synergism ; Gram-Negative Bacteria/drug effects ; Gram-Negative Bacteria/enzymology ; Gram-Negative Bacteria/growth & development ; Humans ; Meropenem/therapeutic use ; Mice ; Molecular Structure ; Peptidomimetics/chemical synthesis ; Peptidomimetics/chemistry ; Peptidomimetics/pharmacology ; beta-Lactamase Inhibitors/chemical synthesis ; beta-Lactamase Inhibitors/chemistry ; beta-Lactamase Inhibitors/pharmacology ; beta-Lactamases/chemistry
Raport
Tytuł :
Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial.
Autorzy :
Kollef MH; Washington University School of Medicine, St Louis, MO, USA.
Nováček M; General Hospital of Kolin, Kolin, Czech Republic.
Kivistik Ü; North Estonia Medical Centre, Tallinn, Estonia.
Réa-Neto Á; Universidade Federal do Paraná, Curitiba, Brazil.
Shime N; Hiroshima University, Hiroshima, Japan.
Martin-Loeches I; St James's Hospital, Dublin, Ireland; Universitat de Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer, Centro de Investigación Biomédica en Red Enfermedades Respiratorias, Barcelona, Spain.
Timsit JF; Université Paris Diderot, Paris, France.
Wunderink RG; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Bruno CJ; Merck & Co, Kenilworth, NJ, USA.
Huntington JA; Merck & Co, Kenilworth, NJ, USA.
Lin G; Merck & Co, Kenilworth, NJ, USA.
Yu B; Merck & Co, Kenilworth, NJ, USA.
Butterton JR; Merck & Co, Kenilworth, NJ, USA.
Rhee EG; Merck & Co, Kenilworth, NJ, USA. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2019 Dec; Vol. 19 (12), pp. 1299-1311. Date of Electronic Publication: 2019 Sep 25.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE
MeSH Terms :
Anti-Bacterial Agents/*therapeutic use
Cephalosporins/*therapeutic use
Cross Infection/*drug therapy
Cross Infection/*microbiology
Meropenem/*therapeutic use
Pneumonia, Bacterial/*drug therapy
Pneumonia, Bacterial/*microbiology
Tazobactam/*therapeutic use
Aged ; Aged, 80 and over ; Anti-Bacterial Agents/pharmacology ; Cephalosporins/pharmacology ; Female ; Humans ; Male ; Meropenem/pharmacology ; Middle Aged ; Tazobactam/pharmacology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
A validated LC-MSMS method for the simultaneous quantification of meropenem and vaborbactam in human plasma and renal replacement therapy effluent and its application to a pharmacokinetic study.
Autorzy :
Parker SL; UQ Centre for Clinical Research, The University of Queensland, Royal Brisbane & Women's Hospital, Brisbane, QLD, 4029, Australia. .
Pandey S; UQ Centre for Clinical Research, The University of Queensland, Royal Brisbane & Women's Hospital, Brisbane, QLD, 4029, Australia.
Sime FB; UQ Centre for Clinical Research, The University of Queensland, Royal Brisbane & Women's Hospital, Brisbane, QLD, 4029, Australia.; Centre for Translational Anti-Infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, QLD, 4029, Australia.
Lipman J; UQ Centre for Clinical Research, The University of Queensland, Royal Brisbane & Women's Hospital, Brisbane, QLD, 4029, Australia.; Department of Intensive Care Medicine, Royal Brisbane & Women's Hospital, Brisbane, QLD, 4029, Australia.
Roberts JA; UQ Centre for Clinical Research, The University of Queensland, Royal Brisbane & Women's Hospital, Brisbane, QLD, 4029, Australia.; Centre for Translational Anti-Infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, QLD, 4029, Australia.; Department of Intensive Care Medicine, Royal Brisbane & Women's Hospital, Brisbane, QLD, 4029, Australia.; Department of Pharmacy, Royal Brisbane & Women's Hospital, Brisbane, QLD, 4029, Australia.
Wallis SC; UQ Centre for Clinical Research, The University of Queensland, Royal Brisbane & Women's Hospital, Brisbane, QLD, 4029, Australia.
Pokaż więcej
Źródło :
Analytical and bioanalytical chemistry [Anal Bioanal Chem] 2019 Nov; Vol. 411 (29), pp. 7831-7840. Date of Electronic Publication: 2019 Nov 16.
Typ publikacji :
Journal Article; Validation Study
Journal Info :
Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134327 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-2650 (Electronic) Linking ISSN: 16182642 NLM ISO Abbreviation: Anal Bioanal Chem Subsets: MEDLINE
MeSH Terms :
Renal Replacement Therapy*
Anti-Bacterial Agents/*blood
Boronic Acids/*blood
Chromatography, Liquid/*methods
Meropenem/*blood
Tandem Mass Spectrometry/*methods
Anti-Bacterial Agents/pharmacokinetics ; Anti-Bacterial Agents/standards ; Boronic Acids/pharmacokinetics ; Boronic Acids/standards ; Calibration ; Humans ; Limit of Detection ; Meropenem/pharmacokinetics ; Meropenem/standards ; Reference Standards
Czasopismo naukowe
Tytuł :
Use of meropenem in treating carbapenem-resistant Enterobacteriaceae infections.
Autorzy :
Pascale R; Infectious Diseases Unit, Department of Medical and Surgical Sciences, Sant'Orsola-Malpighi Hospital, University of Bologna , Bologna , Italy.
Giannella M; Infectious Diseases Unit, Department of Medical and Surgical Sciences, Sant'Orsola-Malpighi Hospital, University of Bologna , Bologna , Italy.
Bartoletti M; Infectious Diseases Unit, Department of Medical and Surgical Sciences, Sant'Orsola-Malpighi Hospital, University of Bologna , Bologna , Italy.
Viale P; Infectious Diseases Unit, Department of Medical and Surgical Sciences, Sant'Orsola-Malpighi Hospital, University of Bologna , Bologna , Italy.
Pea F; Department of Medicine, University of Udine , Udine , Italy.; Institute of Clinical Pharmacology, Santa Maria della Misericordia University Hospital of Udine , Udine , Italy.
Pokaż więcej
Źródło :
Expert review of anti-infective therapy [Expert Rev Anti Infect Ther] 2019 Oct; Vol. 17 (10), pp. 819-827. Date of Electronic Publication: 2019 Oct 08.
Typ publikacji :
Journal Article; Review
Journal Info :
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101181284 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8336 (Electronic) Linking ISSN: 14787210 NLM ISO Abbreviation: Expert Rev Anti Infect Ther Subsets: MEDLINE
MeSH Terms :
Carbapenem-Resistant Enterobacteriaceae/*drug effects
Enterobacteriaceae Infections/*drug therapy
Meropenem/*administration & dosage
Anti-Bacterial Agents/administration & dosage ; Anti-Bacterial Agents/pharmacokinetics ; Anti-Bacterial Agents/pharmacology ; Carbapenem-Resistant Enterobacteriaceae/isolation & purification ; Dose-Response Relationship, Drug ; Drug Monitoring ; Enterobacteriaceae Infections/microbiology ; Humans ; Infusions, Intravenous ; Meropenem/pharmacokinetics ; Meropenem/pharmacology ; Microbial Sensitivity Tests
Czasopismo naukowe
Tytuł :
Plasma and synovial fluid pharmacokinetics of a single intravenous dose of meropenem in adult horses.
Autorzy :
Langston VC; Department of Clinical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi.
Fontenot RL; Department of Clinical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi.
Byers JA; Department of Clinical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi.
Andrews CM; Department of Clinical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi.
Mochal-King CA; Department of Clinical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi.
Pokaż więcej
Źródło :
Journal of veterinary pharmacology and therapeutics [J Vet Pharmacol Ther] 2019 Sep; Vol. 42 (5), pp. 525-529. Date of Electronic Publication: 2019 Jun 20.
Typ publikacji :
Clinical Trial, Veterinary; Journal Article
Journal Info :
Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7910920 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2885 (Electronic) Linking ISSN: 01407783 NLM ISO Abbreviation: J. Vet. Pharmacol. Ther. Subsets: MEDLINE
MeSH Terms :
Anti-Bacterial Agents/*pharmacokinetics
Horses/*blood
Meropenem/*pharmacokinetics
Synovial Fluid/*chemistry
Animals ; Anti-Bacterial Agents/administration & dosage ; Anti-Bacterial Agents/blood ; Anti-Bacterial Agents/chemistry ; Area Under Curve ; Half-Life ; Meropenem/administration & dosage ; Meropenem/blood ; Meropenem/chemistry
Czasopismo naukowe
Tytuł :
Poly (bromocresol green) flakes-decorated pencil graphite electrode for selective electrochemical sensing applications and pharmacokinetic studies.
Autorzy :
Gadallah MI; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assuit University, 71526 Assuit, Egypt. Electronic address: .
Ali HRH; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assuit University, 71526 Assuit, Egypt.
Askal HF; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assuit University, 71526 Assuit, Egypt.
Saleh GA; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assuit University, 71526 Assuit, Egypt.
Pokaż więcej
Źródło :
Materials science & engineering. C, Materials for biological applications [Mater Sci Eng C Mater Biol Appl] 2019 Sep; Vol. 102, pp. 634-645. Date of Electronic Publication: 2019 Mar 23.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101484109 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-0191 (Electronic) Linking ISSN: 09284931 NLM ISO Abbreviation: Mater Sci Eng C Mater Biol Appl Subsets: MEDLINE
MeSH Terms :
Biosensing Techniques/*methods
Bromcresol Green/*chemistry
Electrochemical Techniques/*methods
Ertapenem/*pharmacokinetics
Graphite/*chemistry
Meropenem/*pharmacokinetics
Animals ; Electrodes ; Ertapenem/administration & dosage ; Ertapenem/blood ; Hydrogen-Ion Concentration ; Limit of Detection ; Male ; Meropenem/administration & dosage ; Meropenem/blood ; Oxidation-Reduction ; Rabbits ; Time Factors
Czasopismo naukowe
Tytuł :
Cerebrospinal pharmacokinetic and pharmacodynamic analysis of efficacy of meropenem in paediatric patients with bacterial meningitis.
Autorzy :
Ohata Y; Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd, Osaka, Japan.
Tomita Y; Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd, Osaka, Japan.
Sunakawa K; Kitasato University Research Organization for Infection Control Science, Tokyo, Japan.
Drusano GL; Institute for Therapeutic Innovation, College of Medicine, University of Florida, Gainesville, FL, USA.
Tanigawara Y; Department of Clinical Pharmacokinetics and Pharmacodynamics, Keio University School of Medicine, Tokyo, Japan. Electronic address: .
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2019 Sep; Vol. 54 (3), pp. 292-300. Date of Electronic Publication: 2019 Jul 03.
Typ publikacji :
Journal Article; Meta-Analysis
Journal Info :
Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7913 (Electronic) Linking ISSN: 09248579 NLM ISO Abbreviation: Int. J. Antimicrob. Agents Subsets: MEDLINE
MeSH Terms :
Anti-Bacterial Agents/*pharmacokinetics
Anti-Bacterial Agents/*pharmacology
Cerebrospinal Fluid/*chemistry
Meningitis, Bacterial/*drug therapy
Meropenem/*pharmacokinetics
Meropenem/*pharmacology
Anti-Bacterial Agents/administration & dosage ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Meropenem/administration & dosage ; Microbial Sensitivity Tests ; Microbial Viability/drug effects ; Pneumococcal Infections/drug therapy ; Pseudomonas Infections/drug therapy ; Pseudomonas aeruginosa/drug effects ; Streptococcus pneumoniae/drug effects
Czasopismo naukowe
Tytuł :
Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial.
Autorzy :
Cisneros JM; Department of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBIS), University Hospital Virgen del Rocio CSIC, University of Seville, Avenida Manuel Siurot s/n, 41013, Seville, Spain. .
Rosso-Fernández CM; Clinical Trial Unit, Hospital Universitario Virgen del Rocío, Avenida Manuel Siurot s/n, 41013, Seville, Spain.
Roca-Oporto C; Department of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBIS), University Hospital Virgen del Rocio CSIC, University of Seville, Avenida Manuel Siurot s/n, 41013, Seville, Spain.
De Pascale G; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Jiménez-Jorge S; Clinical Trial Unit, Hospital Universitario Virgen del Rocío, Avenida Manuel Siurot s/n, 41013, Seville, Spain.
Fernández-Hinojosa E; Intensive Care Clinical Unit, Hospital Universitario Virgen del Rocío, Avenida Manuel Siurot s/n, 41013, Seville, Spain.
Matthaiou DK; Department of Critical Care, University Hospital ATTIKON, National and Kapodistrian University of Athens, Athens, Greece.
Ramírez P; Intensive Medicine Unit, Hospital Universitario y Politécnico La Fe, Avinguda de Fernando Abril Martorell, 106, 46026, Valencia, Spain.
Díaz-Miguel RO; Intensive Medicine Unit, Hospital General Universitario de Ciudad Real, Calle Obispo Rafael Torija s/n, 13005, Ciudad Real, Spain.
Estella A; Intensive Care Unit, Hospital Universitario de Jerez, Carretera Nacional IV s/n, 11407, Jerez de la Frontera, Cádiz, Spain.
Antonelli M; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Università Cattolica del Sacro Cuore, Rome, Italy.
Dimopoulos G; Department of Critical Care, University Hospital ATTIKON, National and Kapodistrian University of Athens, Athens, Greece.
Garnacho-Montero J; Intensive Care Clinical Unit, Hospital Universitario Virgen Macarena, Calle Dr. Fedriani, 3, 41009, Seville, Spain.
Pokaż więcej
Corporate Authors :
Magic Bullet Working Group WP1
Źródło :
Critical care (London, England) [Crit Care] 2019 Nov 28; Vol. 23 (1), pp. 383. Date of Electronic Publication: 2019 Nov 28.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info :
Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 9801902 Publication Model: Electronic Cited Medium: Internet ISSN: 1466-609X (Electronic) Linking ISSN: 13648535 NLM ISO Abbreviation: Crit Care Subsets: MEDLINE
MeSH Terms :
Colistin/*standards
Meropenem/*standards
Pneumonia, Ventilator-Associated/*drug therapy
Aged ; Anti-Bacterial Agents/adverse effects ; Anti-Bacterial Agents/standards ; Anti-Bacterial Agents/therapeutic use ; Colistin/adverse effects ; Colistin/therapeutic use ; Equivalence Trials as Topic ; Female ; Humans ; Male ; Meropenem/adverse effects ; Meropenem/therapeutic use ; Middle Aged ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Plasma and Renal Cortex Meropenem Concentrations in Patients Undergoing Percutaneous Renal Biopsy.
Autorzy :
Sepúlveda RA; Department of Nephrology, Facultad de Medicina Pontificia Universidad Católica de Chile, Santiago, Chile.
Downey P; Department of Nephrology, Facultad de Medicina Pontificia Universidad Católica de Chile, Santiago, Chile.
Soto D; Department of Intensive Medicine, Facultad de Medicina Pontificia Universidad Católica de Chile, Santiago, Chile.
Wong KY; State Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Kowloon, Hong Kong.
Leung YC; State Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Kowloon, Hong Kong.
So LY; State Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Kowloon, Hong Kong.
Andresen M; Department of Intensive Medicine, Facultad de Medicina Pontificia Universidad Católica de Chile, Santiago, Chile.
Pokaż więcej
Źródło :
BioMed research international [Biomed Res Int] 2019 Nov 19; Vol. 2019, pp. 1368397. Date of Electronic Publication: 2019 Nov 19 (Print Publication: 2019).
Typ publikacji :
Journal Article
Journal Info :
Publisher: Hindawi Pub. Co Country of Publication: United States NLM ID: 101600173 Publication Model: eCollection Cited Medium: Internet ISSN: 2314-6141 (Electronic) NLM ISO Abbreviation: Biomed Res Int Subsets: MEDLINE
MeSH Terms :
Anti-Bacterial Agents/*blood
Anti-Bacterial Agents/*metabolism
Kidney Cortex/*metabolism
Meropenem/*blood
Meropenem/*metabolism
Plasma/*metabolism
Anti-Bacterial Agents/therapeutic use ; Bacterial Infections/blood ; Bacterial Infections/drug therapy ; Bacterial Infections/metabolism ; Biopsy/methods ; Drug Resistance, Multiple, Bacterial/physiology ; Female ; Glomerular Filtration Rate/physiology ; Humans ; Male ; Meropenem/therapeutic use ; Middle Aged ; Shock, Septic/blood ; Shock, Septic/drug therapy ; Shock, Septic/metabolism ; Urinary Tract Infections/blood ; Urinary Tract Infections/drug therapy ; Urinary Tract Infections/metabolism
Czasopismo naukowe
Tytuł :
Pharmacodynamic Effects of Sulbactam/Meropenem/Polymyxin-B Combination Against Extremely Drug Resistant Acinetobacter baumannii Using Checkerboard Information.
Autorzy :
Menegucci TC; Laboratório de Microbiologia Médica, Departamento de Ciências Básicas da Saúde, Universidade Estadual de Maringá, Maringá, Brazil.
Fedrigo NH; Laboratório de Microbiologia Médica, Departamento de Ciências Básicas da Saúde, Universidade Estadual de Maringá, Maringá, Brazil.
Lodi FG; Laboratório de Microbiologia Médica, Departamento de Ciências Básicas da Saúde, Universidade Estadual de Maringá, Maringá, Brazil.
Albiero J; Laboratório de Microbiologia Médica, Departamento de Ciências Básicas da Saúde, Universidade Estadual de Maringá, Maringá, Brazil.
Nishiyama SAB; Laboratório de Microbiologia Médica, Departamento de Ciências Básicas da Saúde, Universidade Estadual de Maringá, Maringá, Brazil.
Mazucheli J; Programa de Pós-Graduação em Bioestatística, Departamento de Estatística, Universidade Estadual de Maringá, Maringá, Brazil.
Carrara-Marroni FE; Departamento de Patologia, Análises Clínicas e Toxicológicas, Universidade Estadual de Londrina, Maringá, Brazil.
Voelkner NMF; Department of Neuroscience, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois.
Gong H; Department of Mathematics and Statistics, Valparaiso University, Valparaiso, Indiana.
Sy SKB; Programa de Pós-Graduação em Bioestatística, Departamento de Estatística, Universidade Estadual de Maringá, Maringá, Brazil.
Tognim MCB; Laboratório de Microbiologia Médica, Departamento de Ciências Básicas da Saúde, Universidade Estadual de Maringá, Maringá, Brazil.
Pokaż więcej
Źródło :
Microbial drug resistance (Larchmont, N.Y.) [Microb Drug Resist] 2019 Nov; Vol. 25 (9), pp. 1266-1274. Date of Electronic Publication: 2019 Jun 19.
Typ publikacji :
Comparative Study; Journal Article
Journal Info :
Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 9508567 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1931-8448 (Electronic) Linking ISSN: 10766294 NLM ISO Abbreviation: Microb. Drug Resist. Subsets: MEDLINE
MeSH Terms :
Acinetobacter baumannii/*drug effects
Anti-Bacterial Agents/*pharmacology
Meropenem/*pharmacology
Polymyxin B/*pharmacology
Sulbactam/*pharmacology
Acinetobacter Infections/drug therapy ; Acinetobacter Infections/microbiology ; Acinetobacter baumannii/isolation & purification ; Anti-Bacterial Agents/administration & dosage ; Anti-Bacterial Agents/pharmacokinetics ; Area Under Curve ; Dose-Response Relationship, Drug ; Drug Combinations ; Drug Resistance, Multiple, Bacterial ; Drug Synergism ; Humans ; Meropenem/administration & dosage ; Meropenem/pharmacokinetics ; Microbial Sensitivity Tests ; Polymyxin B/administration & dosage ; Polymyxin B/pharmacokinetics ; Sulbactam/administration & dosage ; Sulbactam/pharmacokinetics
Czasopismo naukowe
Tytuł :
Variation in the formation of persister cells against meropenem in Klebsiella pneumoniae bacteremia and analysis of its clinical features.
Autorzy :
Lee JS; Division of Infectious Diseases, Department of Medicine, Hallym University Kangdong Sacred Heart Hospital, Seoul, South Korea.
Choi JY; Department of Molecular Cell Biolog\y, Sungkyunkwan University School of Medicine, Suwon, South Korea.
Chung ES; Department of Molecular Cell Biolog\y, Sungkyunkwan University School of Medicine, Suwon, South Korea.
Peck KR; Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Ko KS; Department of Molecular Cell Biolog\y, Sungkyunkwan University School of Medicine, Suwon, South Korea. Electronic address: .
Pokaż więcej
Źródło :
Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2019 Nov; Vol. 95 (3), pp. 114853. Date of Electronic Publication: 2019 Jun 14.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8305899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0070 (Electronic) Linking ISSN: 07328893 NLM ISO Abbreviation: Diagn. Microbiol. Infect. Dis. Subsets: MEDLINE
MeSH Terms :
Anti-Bacterial Agents/*pharmacology
Bacteremia/*microbiology
Klebsiella Infections/*microbiology
Klebsiella pneumoniae/*drug effects
Klebsiella pneumoniae/*isolation & purification
Meropenem/*pharmacology
Adult ; Aged ; Aged, 80 and over ; Anti-Bacterial Agents/therapeutic use ; Bacteremia/drug therapy ; Drug Tolerance ; Female ; Genotype ; Humans ; Klebsiella Infections/drug therapy ; Klebsiella pneumoniae/genetics ; Male ; Meropenem/therapeutic use ; Microbial Sensitivity Tests ; Microbial Viability/drug effects ; Middle Aged ; Phenotype
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies